183 related articles for article (PubMed ID: 28060141)
1. PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes.
Bolze PA; Patrier S; Massardier J; Hajri T; Abbas F; Schott AM; Allias F; Devouassoux-Shisheboran M; Freyer G; Golfier F; You B
Int J Gynecol Cancer; 2017 Mar; 27(3):554-561. PubMed ID: 28060141
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases.
Veras E; Kurman RJ; Wang TL; Shih IM
Int J Gynecol Pathol; 2017 Mar; 36(2):146-153. PubMed ID: 27362903
[TBL] [Abstract][Full Text] [Related]
3. Analysis of PD-L1 expression in trophoblastic tissues and tumors.
Lu B; Teng X; Fu G; Bao L; Tang J; Shi H; Lu W; Lu Y
Hum Pathol; 2019 Feb; 84():202-212. PubMed ID: 30339966
[TBL] [Abstract][Full Text] [Related]
4. PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia.
Zong L; Zhang M; Wang W; Wan X; Yang J; Xiang Y
Histopathology; 2019 Sep; 75(3):421-430. PubMed ID: 31013360
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 in gestational trophoblastic disease: an antibody evaluation.
Hoeijmakers YM; Simons M; Bulten J; Gorris MAJ; Ottevanger PB; de Vries IJM; Sweep FCGJ
Acta Obstet Gynecol Scand; 2022 Sep; 101(9):1007-1016. PubMed ID: 35689468
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern of the activating protein-1 family of transcription factors in gestational trophoblastic lesions.
Briese J; Sudahl S; Schulte HM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2005 Jul; 24(3):265-70. PubMed ID: 15968203
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase expression in gestational trophoblastic diseases.
Barut A; Harma M; Arikan I; Harma MI; Barut F
Int J Gynecol Cancer; 2010 Apr; 20(3):337-40. PubMed ID: 20375793
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors.
Inaguma S; Wang Z; Lasota J; Sarlomo-Rikala M; McCue PA; Ikeda H; Miettinen M
Am J Surg Pathol; 2016 Aug; 40(8):1133-42. PubMed ID: 27158757
[TBL] [Abstract][Full Text] [Related]
9. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin expression in gestational trophoblastic diseases: correlation with expression of the adhesion molecule, CEACAM1.
Briese J; Oberndörfer M; Schulte HM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2005 Jul; 24(3):271-6. PubMed ID: 15968204
[TBL] [Abstract][Full Text] [Related]
11. Versican silencing in BeWo cells and its implication in gestational trophoblastic diseases.
Pires KSN; Sun SY; Gonçalves CM; Santos JC; Tenorio LPG; Botelho RM; Silva ALM; Oliveira HGS; Pendeloski KPT; Daher S; Borbely KSC; Borbely AU
Histochem Cell Biol; 2019 Apr; 151(4):305-313. PubMed ID: 30298299
[TBL] [Abstract][Full Text] [Related]
12. Whole transcriptome analysis of gestational trophoblastic neoplasms reveals altered PI3K signaling pathway in epithelioid trophoblastic tumor.
Cho EJ; Chun SM; Park H; Sung CO; Kim KR
Gynecol Oncol; 2020 Apr; 157(1):151-160. PubMed ID: 31954539
[TBL] [Abstract][Full Text] [Related]
13. [Gestational trophoblastic disease, Villous gestational trophoblastic disease].
Vogel M; Horn LC
Pathologe; 2004 Jul; 25(4):269-79. PubMed ID: 15197483
[TBL] [Abstract][Full Text] [Related]
14. Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug-resistant gestational trophoblastic neoplasia: Four case reports and literature review.
Liu W; Zhu Y; Wang Y; Li R; Zou D; Chen R; Yang L; Huang Y
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2016. PubMed ID: 38425251
[TBL] [Abstract][Full Text] [Related]
15. p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases.
Shoni M; Nagymanyoki Z; Vitonis AF; Jimenez C; Ng SW; Quade BJ; Berkowitz RS
Gynecol Oncol; 2013 Dec; 131(3):759-63. PubMed ID: 24051221
[TBL] [Abstract][Full Text] [Related]
16. [Gestational trophoblastic disease. Non-villous forms of gestational trophoblastic disease].
Horn LC; Vogel M
Pathologe; 2004 Jul; 25(4):281-91. PubMed ID: 15184992
[TBL] [Abstract][Full Text] [Related]
17. SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor.
Stichelbout M; Devisme L; Franquet-Ansart H; Massardier J; Vinatier D; Renaud F; Kerdraon O
Hum Pathol; 2016 Aug; 54():121-6. PubMed ID: 27068524
[TBL] [Abstract][Full Text] [Related]
18. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
20. Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions.
Yagyuu T; Hatakeyama K; Imada M; Kurihara M; Matsusue Y; Yamamoto K; Obayashi C; Kirita T
Oral Oncol; 2017 May; 68():36-43. PubMed ID: 28438290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
